Drugmaker Bristol-Myers Squibb announced a $74 billion deal to buy Celgene, in one of the biggest mergers in pharmaceutical industry history.
[van id=”business/2019/01/03/bristol-myers-squibb-celgene-merger.cnn-business”]
[van id=”business/2019/01/03/bristol-myers-squibb-celgene-merger.cnn-business”]